RESUMEN
Isoflavonoids have been largely studied due to their distinct biological activities identified thus far. Herein, we evaluated the activity of neovestitol, an isoflavonoid isolated from Brazilian red propolis, in acute and chronic inflammation. As for acute inflammation, we found that neovestitol reduced neutrophil migration, leukocyte rolling and adhesion, as well as expression of ICAM-1 in the mesenteric microcirculation during lipopolysaccharide-induced acute peritonitis. No changes were observed in the levels of TNF-α, CXCL1/KC and CXCL2/MIP-2 upon pretreatment with neovestitol. The administration of an inducible nitric oxide synthase (iNOS) inhibitor abolished the inhibitory effects of neovestitol in neutrophil migration and ICAM-1 expression. Nitrite levels increased upon treatment with neovestitol. No effects of neovestitol were observed on the chemotaxis of neutrophils in vitro. As for chronic inflammation, neovestitol also reduced the clinical score and joint damage in a collagen-induced arthritis model. There was no change in the frequency of IL-17-producing TCD4+ cells. In addition, pretreatment with neovestitol reduced the levels of IL-6. These results demonstrate a potential anti-inflammatory activity of neovestitol, which may be useful for therapeutic purposes and/or as a nutraceutical.
Asunto(s)
Artritis Experimental/prevención & control , Flavonoides/uso terapéutico , Interleucina-6/metabolismo , Óxido Nítrico/metabolismo , Peritonitis/prevención & control , Própolis/química , Enfermedad Aguda , Animales , Antiinflamatorios/química , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Artritis Experimental/etiología , Brasil , Linfocitos T CD4-Positivos/citología , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/metabolismo , Línea Celular , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Enfermedad Crónica , Citocinas/metabolismo , Flavonoides/química , Flavonoides/farmacología , Guanidinas/farmacología , Lipopolisacáridos/toxicidad , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/metabolismo , Venas Mesentéricas/patología , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Neutrófilos/citología , Neutrófilos/efectos de los fármacos , Neutrófilos/inmunología , Peritonitis/etiología , Própolis/metabolismoRESUMEN
BACKGROUND: Mesenteric phlebosclerosis (MP) is a disease characterized by fibrotic change or calcification of the mesenteric vein. Recently, there has been an increase in case reports of MP related to herbal medicine usage. Long-term intake of gardenia fruit (GF) is suspected as a possible cause. However, many GF users do not develop this disease and the association between GF and MP remains unclear. In this study, we investigated for the first time the dosage of GF used by patients with and without MP. METHODS: We used a medical chart review study design to assess the association between GF and MP. We reviewed patients with a history of intake of herbal medicines containing GF. Among these patients, we selected patients who were examined by colonoscopy and abdominal plain computed tomography (CT). We investigated the findings of colonoscopy, CT scan and histological examination. We assessed the total dosages of GF alongside the duration of ambulatory visit, the administration period of herbal medicine containing GF and pre-existing disease in order to compare MP cases and non-MP patients. RESULTS: Ten MP cases and 42 non-MP patients were analyzed. We summarized clinical findings of MP cases. All MP cases used more GF than non-MP patients and were administered more than approximately 5,000 grams of GF in cumulative dosage. CONCLUSIONS: This study indicated that excessive intake of GF contributes to and/or accelerates the development of MP suggesting that long-term usage of GF in excessive amounts increases the risk of MP.
Asunto(s)
Gardenia/química , Venas Mesentéricas/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Extractos Vegetales/efectos adversos , Plantas Medicinales/química , Calcificación Vascular/inducido químicamente , Anciano , Femenino , Frutas/química , Humanos , Masculino , Venas Mesentéricas/fisiopatología , Persona de Mediana Edad , Fitoterapia/estadística & datos numéricos , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Calcificación Vascular/epidemiologíaRESUMEN
OBJECTIVE: Mesenteric phlebosclerosis (MP) is a disease characterized by calcification of the mesenteric vein, which causes chronic mesenteric ischemia. Recently, the long-term intake of gardenia fruit ('Sanshishi' in Japanese) has been attracting attention as a possible cause. Usually, only advanced, severe MP cases get reported. However, we suspected that some latent cases of this disease may exist. We performed this study in order to determine the prediagnostic cases at our outpatient departments of herbal (Kampo) medicine, with particular attention paid to the initial changes, such as any slight color change of the colon, as shown in colonoscopy. METHODS: We recommend colonoscopy and computed tomography (CT) scans for patients with a long-term history of taking herbal medicines containing gardenia fruit. Clinical examinations were performed upon receiving patients' consent from December 2013 to November 2014. RESULTS: Of the 103 patients who took gardenia fruit long-term, 29 agreed to be checked for MP. 14 patients underwent colonoscopy. Four patients were confirmed to have MP due to the presence of fibrotic deposition of the colonic membrane on histological inspection. Twenty-one patients underwent abdominal CT screening. Characteristic calcification of the mesenteric vein was observed on CT scans in 2 patients. All 4 MP patients took Kampo formulas containing gardenia fruit for more than 6.8 years. The other patients did not develop MP, despite long-term gardenia fruit intake. CONCLUSION: We detected the latent and undiagnosed MP cases. All diagnoses were made while paying careful attention to any slight changes in colonoscopy and CT scans.
Asunto(s)
Arteriosclerosis/patología , Calcinosis/patología , Colon/patología , Colonoscopía , Gardenia/toxicidad , Medicina Kampo/métodos , Venas Mesentéricas/patología , Plantas Medicinales/efectos adversos , Tomografía Computarizada por Rayos X , Adulto , Anciano , Arteriosclerosis/inducido químicamente , Calcinosis/inducido químicamente , Femenino , Humanos , Japón , Masculino , Medicina Kampo/efectos adversos , Venas Mesentéricas/efectos de los fármacos , Persona de Mediana EdadRESUMEN
Mammalian gastrointestinal systems are constantly exposed to compounds (desirable and undesirable) that can have an effect on blood flow to and from that system. Changes in blood flow to the small intestine can result in effects on the absorptive functions of the organ. Particular interest in toxins liberated from feedstuffs through fermentative and digestive processes has developed in ruminants as an area where productive efficiencies could be improved. The video associated with this article describes an in vitro bioassay developed to screen compounds for vasoactivity in isolated cross-sections of bovine mesenteric artery and vein using a multimyograph. Once the blood vessels are mounted and equilibrated in the myograph, the bioassay itself can be used: as a screening tool to evaluate the contractile response or vasoactivity of compounds of interest; determine the presence of receptor types by pharmacologically targeting receptors with specific agonists; determine the role of a receptor with the presence of one or more antagonists; or determine potential interactions of compounds of interest with antagonists. Through all of this, data are collected real-time, tissue collected from a single animal can be exposed to a large number of different experimental treatments (an in vitro advantage), and represents vasculature on either side of the capillary bed to provide an accurate picture of what could be happening in the afferent and efferent blood supply supporting the small intestine.
Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Intestino Delgado/irrigación sanguínea , Arterias Mesentéricas/efectos de los fármacos , Venas Mesentéricas/efectos de los fármacos , Circulación Esplácnica/efectos de los fármacos , Animales , Bovinos , Alcaloides de Claviceps/farmacocinética , Alcaloides de Claviceps/farmacología , Técnicas In Vitro , Absorción Intestinal/efectos de los fármacos , Arterias Mesentéricas/metabolismo , Venas Mesentéricas/metabolismoRESUMEN
We recently observed that maternal 18:3n-3 increases piglet jejunal permeability. We hypothesized that this would favor intestinal lipopolysaccharide (LPS) passage and alter gut immune system education toward this bacterial ligand. Sows were fed 18:3n-3 or 18:2n-6 diets throughout gestation and lactation. In each litter, two piglets were given oral Gram-negative spectrum antibiotic from post-natal day (PND) 14 to 28. All piglets were weaned on a regular diet at PND28. 18:3n-3 piglets exhibited greater jejunal permeability to FITC-LPS at PND28. Levels of 18:3n-3 but neither 20:5n-3 nor 20:4n-6 were greater in mesenteric lymph nodes (MLN) of 18:3n-3 piglets. Jejunal explant or MLN cell cytokine responses to LPS were not influenced by the maternal diet. Antibiotic increased jejunal permeability to FITC-LPS and lowered the level of 20:5n-3 in MLN, irrespective of the maternal diet. At PND52, no long-lasting effect of the maternal diet or antibiotic treatment on jejunal permeability was noticed. 18:3n-3 and 20:4n-6 levels were greater and lower, respectively, in MLN of 18:3n-3 compared to 18:2n-6 piglets. IL-10 production by MLN cells in response to LPS was greater in the 18:3n-3 group, irrespective of the neonatal antibiotic treatment. IL-8 secretion by jejunal explants in response to LPS was lower in antibiotic-treated 18:3n-3 compared to 18:2n-6 piglets. Finally, proportion of MHC class II(+) antigen-presenting cells was greater in 18:3n-3 than 18:2n-6 MLN cells. In conclusion, maternal 18:3n-3 directs the intestinal immune response to LPS toward an anti-inflammatory profile beyond the breastfeeding period; microbiota involvement seems dependent of the immune cells considered.
Asunto(s)
Ácidos Grasos Omega-3/farmacología , Yeyuno/efectos de los fármacos , Lipopolisacáridos/efectos adversos , Animales , Animales Recién Nacidos , Células Cultivadas , Citocinas/metabolismo , ADN Bacteriano/genética , Dieta/veterinaria , Ácidos Grasos Omega-6/farmacología , Femenino , Inflamación/patología , Yeyuno/inmunología , Yeyuno/microbiología , Fenómenos Fisiologicos Nutricionales Maternos , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/metabolismo , Microbiota , Permeabilidad , Embarazo , Resultado del Embarazo , Porcinos , DesteteRESUMEN
Endothelial cells in a cultured monolayer change from a "cobblestone" configuration when grown under static conditions to a more elongated shape, aligned with the direction of flow, after exposure to sustained uniform shear stress. Sustained blood flow acts to protect regions of large arteries from injury. We tested the hypothesis that the stable permeability state of individually perfused microvessels is also characteristic of flow conditioning. In individually perfused rat mesenteric venular microvessels, microvascular permeability, measured as hydraulic conductivity (Lp), was stable [mean 1.0 × 10(-7) cm/(s × cmH2O)] and independent of shear stress (3-14 dyn/cm(2)) for up to 3 h. Vessels perfused opposite to the direction of normal blood flow exhibited a delayed Lp increase [ΔLp was 7.6 × 10(-7) cm/(s × cmH2O)], but the increase was independent of wall shear stress. Addition of chondroitin sulfate and hyaluronic acid to perfusates increased the shear stress range, but did not modify the asymmetry in response to flow direction. Increased Lp in reverse-perfused vessels was associated with numerous discontinuities of VE-cadherin and occludin, while both proteins were continuous around the periphery of forward-perfused vessels. The results are not consistent with a general mechanism for graded shear-dependent permeability increase, but they are consistent with the idea that a stable Lp under normal flow contributes to prevention of edema formation and also enables physiological regulation of shear-dependent small solute permeabilities (e.g., glucose). The responses during reverse flow are consistent with reports that disturbed flows result in a less stable endothelial barrier in venular microvessels.
Asunto(s)
Permeabilidad Capilar/fisiología , Células Endoteliales/fisiología , Hemorreología/fisiología , Microcirculación/fisiología , Vénulas/fisiología , Agua/metabolismo , Animales , Antígenos CD/metabolismo , Cadherinas/metabolismo , Permeabilidad Capilar/efectos de los fármacos , Adhesión Celular , Sulfatos de Condroitina/farmacología , Células Endoteliales/efectos de los fármacos , Glicocálix/efectos de los fármacos , Glicocálix/fisiología , Ácido Hialurónico/farmacología , Masculino , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/fisiología , Microcirculación/efectos de los fármacos , Ocludina/metabolismo , Ratas , Ratas Sprague-Dawley , Vénulas/efectos de los fármacos , Viscosuplementos/farmacologíaRESUMEN
INTRODUCTION: Thermal injuries with more than 20% of burned body surface area (BSA) lead to systemic shock with generalised oedema in addition to local tissue destruction. This condition, known as burn injury, is caused by immunmodulative mediators whose individual significance is not known in detail. We present an experimental model where plasma of burned animals (burn plasma) is transmitted to healthy animals, to trigger burn iniury without performing direct burn trauma. MATERIAL AND METHODS: The systemic oedema is measured by extravasation of fluorescent albumin in mesenterial venules of Wistar rats. In addition, leukocyte-endothelial interactions ("leukocyte rolling and sticking") is examined. RESULTS: The systemic capillary leak is induced by both direct thermal trauma as well as by infusion of burn plasma. This is evident even after plasma dilution (1% in Ringer's lactate) of the burn plasma. In addition, topical therapy for burned animals (donors) with cerium nitrate led to a significant reduction of plasma extravasation in receiver animals. In addition, systemic antioxidant therapy with high-dose vitamin C of receiver animals, led to a significant reduction of the capillary leak. Leukocyte-endothelial interactions are not significantly affected in either case. CONCLUSION: In summary, for the first time a reliable model of burn injury has been established, which eliminates mediator-independent effects. In addition, our studies show that antioxidant therapy with high doses of vitamin C and topical treatment with cerium nitrate both reduce the systemic capillary leak in receiver animals. Their positive influence could therefore soon be integrated in clinical treatment algorithms.
Asunto(s)
Quemaduras/inmunología , Síndrome de Fuga Capilar/inmunología , Adhesión Celular/inmunología , Citocinas/fisiología , Modelos Animales de Enfermedad , Edema/inmunología , Leucocitos/inmunología , Microcirculación/inmunología , Plasma/inmunología , Choque/inmunología , Animales , Antiinfecciosos Locales/farmacología , Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Velocidad del Flujo Sanguíneo/fisiología , Quemaduras/tratamiento farmacológico , Síndrome de Fuga Capilar/tratamiento farmacológico , Adhesión Celular/efectos de los fármacos , Cerio/farmacología , Extravasación de Materiales Terapéuticos y Diagnósticos , Leucocitos/efectos de los fármacos , Masculino , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/inmunología , Microcirculación/efectos de los fármacos , Ratas , Ratas Wistar , Choque/tratamiento farmacológico , Vénulas/efectos de los fármacos , Vénulas/inmunologíaRESUMEN
Extract from seeds and bark of horse chestnut (Aesculus hippocastanum L) is used as an herbal medicine against chronic venous insufficiency. The effect and mechanism of action on veins, arteries, and platelets are not fully understood. The aim of this study was to investigate the effects and mechanisms of action of horse chestnut on the contraction of bovine mesenteric veins and arteries, and human platelet aggregation. Contraction studies showed that horse chestnut extract dose-dependently contracted both veins and arteries, with the veins being the most sensitive. Contraction of both veins and arteries were significantly inhibited by the 5-HT(2A) receptor antagonist ketanserin. No effect on contraction was seen with the cyclooxygenase inhibitor indomethacin, the alpha(1) receptor antagonist prazosin or the angiotensin AT(1) receptor antagonist saralasin neither in veins nor arteries. ADP-induced human platelet aggregation was significantly reduced by horse chestnut. A further reduction was seen with the extract in the presence of ketanserin. In conclusion, horse chestnut contraction of both veins and arteries is, at least partly, mediated through 5-HT(2A) receptors. Human platelet aggregation is reduced by horse chestnut. The clinical importance of these findings concerning clinical use, possible adverse effects, and drug interactions remains to be investigated.
Asunto(s)
Aesculus , Contracción Muscular/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Extractos Vegetales/farmacología , Agregación Plaquetaria/efectos de los fármacos , Receptor de Serotonina 5-HT2A/metabolismo , Agonistas del Receptor de Serotonina 5-HT2/farmacología , Adenosina Difosfato , Antagonistas de Receptores Adrenérgicos alfa 1/farmacología , Bloqueadores del Receptor Tipo 1 de Angiotensina II/farmacología , Animales , Bovinos , Inhibidores de la Ciclooxigenasa/farmacología , Relación Dosis-Respuesta a Droga , Humanos , Ketanserina/farmacología , Arterias Mesentéricas/efectos de los fármacos , Venas Mesentéricas/efectos de los fármacos , Corteza de la Planta , Inhibidores de Agregación Plaquetaria/farmacología , Semillas , Antagonistas del Receptor de Serotonina 5-HT2/farmacologíaRESUMEN
There is evidence that hyperlipidemia can induce hemorheological and microcirculatory disturbances. Myakuryu, a Chinese traditional medicine is efficacious in promoting lipid metabolism and protecting oxidative stress, but whether this drug can ameliorate rheologic disturbances caused by hyperlipidemia is still unknown. The present study was conducted to investigate the effects of myakuryu on hemorheological and microcirculatory disturbances induced by hyperlipidemia. Wistar rats were divided into a group on control diet (n=8) and a group on high-fat diet (HFD, n=44). Eight weeks later, plasma triglyceride (TG) and total cholesterol (TC) were determined. Sixteen animals with the highest levels of hyperlipidemia from the HFD group were randomly divided into two sub-groups: the untreated hyperlipidemia group (n=8) and the group treated with myakuryu (n=8). At the end of the sixteenth week, rheological and microcirculatory parameters were measured. Chemical analysis showed that myakuryu treatment caused significant reductions of plasma TG and TC levels (P<0.01), and the cholesterol/phospholipid ratio in the erythrocyte membrane (P<0.05). Rheological and microcirculatory measurements showed that myakuryu treatment led to a significant decrease in the erythrocyte aggregation index, plasma viscosity and blood viscosity at shear rates of 50, 100 and 150 s(-1) and in adherent leukocytes in mesenteric venules. There was a significant increase in erythrocyte deformation, electrophoretic mobility, membrane fluidity and F-actin content in the erythrocyte membrane as well as in red cell velocity in mesenteric venules. Our findings suggest that myakuryu treatment can improve blood flow and reduce adherent leukocytes in the venules of rats fed with HFD by ameliorating blood viscosity, erythrocyte deformability and aggregation, and other hemorheological characteristics.
Asunto(s)
Hemorreología/efectos de los fármacos , Hiperlipidemias/sangre , Fitoterapia/métodos , Preparaciones de Plantas/farmacología , Actinas/sangre , Animales , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Viscosidad Sanguínea/efectos de los fármacos , Peso Corporal , Adhesión Celular/efectos de los fármacos , Grasas de la Dieta/administración & dosificación , Evaluación Preclínica de Medicamentos/métodos , Agregación Eritrocitaria/efectos de los fármacos , Membrana Eritrocítica/metabolismo , Hiperlipidemias/tratamiento farmacológico , Hiperlipidemias/fisiopatología , Leucocitos/efectos de los fármacos , Lípidos/sangre , Fluidez de la Membrana/efectos de los fármacos , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/fisiopatología , Microcirculación/efectos de los fármacos , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Preparaciones de Plantas/uso terapéutico , Ratas , Ratas WistarRESUMEN
Epigallocatechin gallate (EGCG), a bioactive polyphenol in green tea, may augment metabolic and vascular actions of insulin. Therefore, we investigated effects of EGCG treatment to simultaneously improve cardiovascular and metabolic function in spontaneously hypertensive rats (SHR; model of metabolic syndrome with hypertension, insulin resistance, and overweight). In acute studies, EGCG (1-100 microM) elicited dose-dependent vasodilation in mesenteric vascular beds (MVB) isolated from SHR ex vivo that was inhibitable by N(omega)-nitro-L-arginine methyl ester (L-NAME; nitric oxide synthase antagonist) or wortmannin [phosphatidylinositol (PI) 3-kinase inhibitor]. In chronic studies, 9-wk-old SHR were treated by gavage for 3 wk with EGCG (200 mg.kg(-1).day(-1)), enalapril (30 mg.kg(-1).day(-1)), or vehicle. A separate group of SHR receiving L-NAME (80 mg/l in drinking water) was treated for 3 wk with either EGCG or vehicle. Vasodilator actions of insulin were significantly improved in MVB from EGCG- or enalapril-treated SHR (when compared with vehicle-treated SHR). Both EGCG and enalapril therapy significantly lowered systolic blood pressure (SBP) in SHR. EGCG therapy of SHR significantly reduced infarct size and improved cardiac function in Langendorff-perfused hearts exposed to ischemia-reperfusion (I/R) injury. In SHR given L-NAME, beneficial effects of EGCG on SBP and I/R were not observed. Both enalapril and EGCG treatment of SHR improved insulin sensitivity and raised plasma adiponectin levels. We conclude that acute actions of EGCG to stimulate production of nitric oxide from endothelium using PI 3-kinase-dependent pathways may explain, in part, beneficial effects of EGCG therapy to simultaneously improve metabolic and cardiovascular pathophysiology in SHR. These findings may be relevant to understanding potential benefits of green tea consumption in patients with the metabolic syndrome.
Asunto(s)
Catequina/análogos & derivados , Endotelio Vascular/efectos de los fármacos , Resistencia a la Insulina/fisiología , Daño por Reperfusión Miocárdica/prevención & control , Vasodilatadores/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Presión Sanguínea/fisiología , Catequina/farmacología , Enalapril/farmacología , Endotelio Vascular/fisiología , Técnicas In Vitro , Masculino , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/fisiología , Daño por Reperfusión Miocárdica/tratamiento farmacológico , NG-Nitroarginina Metil Éster/farmacología , Distribución Aleatoria , Ratas , Ratas Endogámicas SHR , Ratas Endogámicas WF , TéRESUMEN
Oxamniquine is an antiparasitic agent commonly used in therapeutics against Schistosoma mansoni. Although it is well tolerated, some adverse effects justify the search for new compounds with prolonged biological action, so that monomeric and polymeric oxamniquine prodrugs were designed. Synthetic results assisted by molecular modeling study showed the possibility to obtain the corresponding monomeric forms of the oxamniquine methacrylate (1) and oxamniquine acrylamide (2). Successful copolymerization procedure only occurred on the methacrylic compound, generating the oxamniquine methacrylate copolymer (3). Submitted to a preliminary in vivo biological evaluation, a similar oxamniquine profile was observed to the monomeric forms although an inadequate drug release may be responsible for the methacrylic copolymer failure.
Asunto(s)
Acrilamida/síntesis química , Diseño de Fármacos , Metacrilatos/síntesis química , Oxamniquina/síntesis química , Profármacos/síntesis química , Esquistosomicidas/uso terapéutico , Acrilamida/química , Acrilamida/uso terapéutico , Animales , Evaluación Preclínica de Medicamentos , Masculino , Venas Mesentéricas/efectos de los fármacos , Metacrilatos/química , Metacrilatos/uso terapéutico , Ratones , Modelos Moleculares , Oxamniquina/química , Oxamniquina/uso terapéutico , Profármacos/química , Profármacos/uso terapéutico , Schistosoma mansoni/efectos de los fármacos , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomicidas/síntesis química , Relación Estructura-ActividadRESUMEN
OBJECTIVE: to determine whether inhaled nitric oxide (NO) would alter leukocyte kinetics in the septic microvasculature. DESIGN: Randomized, controlled trial. SETTING: Experimental laboratory. SUBJECTS: Male Sprague Dawley rats. INTERVENTIONS: Rats were treated with either saline or endotoxin (10 mg/kg, iv) and then allowed to breathe either air or air plus NO (10 ppm). MEASUREMENTS AND MAIN RESULTS: After a 4-hr period, rolling, firm adhesion, and emigration of leukocytes and endothelial dysfunction were monitored in mesenteric venules by using intravital videomicroscopy. Compared with controls, endotoxemic rats exhibited a profound influx in mesenteric venule rolling leukocytes (55+/-17 vs. 70+/-19 leukocytes/min; p < .05), associated with a reduction of leukocyte rolling velocity (83+/-14 vs. 34+/-3 microm/sec; p < .05). In endotoxemic rats, venular endothelium leukocyte firm adhesion (1.15+/-0.32 vs. 4.08+/-0.96 leukocytes/ 100 microm; p < .05) and emigration (0.84+/-0.47 vs. 4.23+/-1.2 leukocytes/100 microm; p < .05) increased compared with controls. Inhaled NO had no effect on leukocyte kinetics in control rats. Inhaled NO significantly attenuated endotoxin-induced venular endothelium leukocyte adhesion (4.08+/-0.96 vs. 1.86+/-0.76 leukocytes/100 microm; p < .05) and emigration (4.23+/-1.2 vs. 1.68+/-0.72 leukocytes/100 microm; p < .05). Compared with control rats, macromolecular (FITC-dextran) vascular leakage, expressed as the perivenular/intravenular fluorescence intensity ratio, increased in endotoxemic rats (0.56+/-0.02 vs. 0.81+/-0.05; p < .01). Endotoxin-induced macromolecular vascular leakage increases were partially prevented by inhaled NO (0.66+/-0.01 vs. 0.56+/-0.02; p < .05). CONCLUSION: These observations suggest that inhaled NO reduces leukocyte adhesion and the degree of vascular permeability dysfunction in mesenteric venule of endotoxemic rats.
Asunto(s)
Endotoxemia/tratamiento farmacológico , Infecciones por Escherichia coli/tratamiento farmacológico , Leucocitos/efectos de los fármacos , Venas Mesentéricas/efectos de los fármacos , Óxido Nítrico/administración & dosificación , Vasodilatadores/administración & dosificación , Administración por Inhalación , Animales , Permeabilidad Capilar/efectos de los fármacos , Adhesión Celular/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Endotoxemia/sangre , Endotoxemia/fisiopatología , Infecciones por Escherichia coli/sangre , Infecciones por Escherichia coli/fisiopatología , Hemodinámica/efectos de los fármacos , Cinética , Leucocitos/fisiología , Masculino , Venas Mesentéricas/fisiopatología , Óxido Nítrico/farmacología , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Vasodilatadores/farmacología , Vénulas/efectos de los fármacos , Vénulas/fisiopatologíaRESUMEN
In order to investigate the toxic effects of long-term treatment with anthraquinone laxatives, rats were fed either chocolate alone, or chocolate adulterated with senna or danthron (1,8-dihydroxyanthraquinone) for 5 months. Mesenteric blood vessels and the outer muscle layers of the caecum, together with the myenteric plexus, were examined using ultrastructural, histochemical, immunohistochemical and immunoassay techniques. There was no ultrastructural evidence of degeneration in either the mesenteric vessels or the caecum. In the mesenteric vessels, levels of neuropeptide Y were significantly reduced in the danthron-fed rats, but levels of substance P (SP), calcitonin gene-related peptide (CGRP) and vasoactive intestinal polypeptide (VIP) were unaffected by all treatments. In the caecum, VIP-, SP- and CGRP-immunoreactivity and catecholamine-fluorescence were unchanged by the laxative treatments.
Asunto(s)
Catárticos/farmacología , Músculo Liso Vascular/metabolismo , Músculo Liso/metabolismo , Neuropéptidos/metabolismo , Animales , Antraquinonas/farmacología , Cacao/efectos adversos , Ciego/efectos de los fármacos , Ciego/metabolismo , Ciego/ultraestructura , Femenino , Inmunohistoquímica , Arterias Mesentéricas/efectos de los fármacos , Arterias Mesentéricas/metabolismo , Arterias Mesentéricas/ultraestructura , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/metabolismo , Venas Mesentéricas/ultraestructura , Músculo Liso/efectos de los fármacos , Músculo Liso/ultraestructura , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/ultraestructura , Ratas , Ratas Sprague-Dawley , Extracto de Senna/farmacología , Sustancia P/metabolismo , Péptido Intestinal Vasoactivo/metabolismoRESUMEN
We showed earlier that the rostral ventral medulla can be functionally and anatomically divided into the rostral ventrolateral medulla (RVLM) and the rostral ventromedial medulla (RVMM). In this study, we examined the relationship between the lateral hypothalamus and these two medullary sites. Electrical stimulation of the lateral hypothalamus produced a pressor response mediated by increases in renal and mesenteric vascular resistance. Inactivating RVLM had no effect on this response whereas inactivating RVMM significantly blunted the pressor response and the increases in renal and mesenteric resistance. In other studies, inactivating dorsomedullary sites significantly reduced arterial pressure. Unlike RVLM, these depressor responses were not significantly altered by reducing tidal volume. Inactivating sites 0.5 mm medial and lateral to the RVMM, as well as a site 0.5 mm caudal to the RVLM, resulted in depressor responses that were unaffected by reducing tidal volume. However, inactivation of a site 1.0 mm caudal to the RVLM but still within the ventrolateral medullary pressor area, resulted in a depressor response that was enhanced by reduced tidal volume. Together, these data demonstrate a functional differentiation of medullary sites controlling vasomotor outflow.
Asunto(s)
Presión Sanguínea/fisiología , Bulbo Raquídeo/fisiología , Tálamo/fisiología , Animales , Presión Sanguínea/efectos de los fármacos , Estimulación Eléctrica , Inyecciones , Riñón/irrigación sanguínea , Lidocaína/administración & dosificación , Bulbo Raquídeo/efectos de los fármacos , Arterias Mesentéricas/efectos de los fármacos , Arterias Mesentéricas/fisiología , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/fisiología , Ratas , Ratas Endogámicas , Resistencia Vascular/efectos de los fármacos , Resistencia Vascular/fisiologíaRESUMEN
The effects of crude and processed ginger extracts and pungent components, S-(+)-[6]-gingerol and [6]-shogaol, on noradrenaline (NA)- and prostaglandin (PG) F2 alpha-induced contraction were investigated using mouse mesenteric veins. Both spicy constituents inhibited the contractile responses to NA. Crude ginger extract and S-(+)-[6]-gingerol potentiated the PGF2 alpha-induced contraction, whereas processed ginger extract and [6]-shogaol inhibited the contraction.
Asunto(s)
Dinoprost/farmacología , Músculo Liso Vascular/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Catecoles/farmacología , Alcoholes Grasos/farmacología , Técnicas In Vitro , Masculino , Venas Mesentéricas/efectos de los fármacos , Ratones , Contracción Muscular/efectos de los fármacos , EstereoisomerismoRESUMEN
During the experiment conducted upon 85 guinea-pigs it has been found that the injection of naloxone at the dose of 0.5 g/kg half an hour before the reproduction of anaphylactic shock (AS) by the use of horse serum increases the number of cases of the retarded development of pathological reaction and survival of the animals. Except for the quantitative differences mentioned any peculiarities characterizing the effect of naloxone were not found. As to the morphological differences of variants in the course of AS they are distinctly defined only at the analysis of film preparations of the intestinal mesentery. The typical AS becomes apparent by haemorrhages, by dilatation of all the vessels of blood circulation and by forming of erythrocytic aggregates in them. At the retarded development of AS a spasm of precapillaries is observed. After convalescence of the animals the aggregates of erythrocytes can be revealed only in venules. Studying the animals recovered after AS one can find that for a long time these animals had the erythrocytic aggregates in the clearances of venules, as well as the signs of new formation of the capillaries.
Asunto(s)
Anafilaxia/prevención & control , Naloxona/uso terapéutico , Anafilaxia/mortalidad , Anafilaxia/patología , Animales , Evaluación Preclínica de Medicamentos , Cobayas , Inmunización/métodos , Arterias Mesentéricas/efectos de los fármacos , Arterias Mesentéricas/patología , Venas Mesentéricas/efectos de los fármacos , Venas Mesentéricas/patología , Microcirculación/efectos de los fármacos , Microcirculación/patología , Factores de TiempoRESUMEN
In helical strips of dog mesenteric, coronary and cerebral arteries and mesenteric veins contracted with prostaglandin F2 alpha, sophoramine (10(-4) and 10(-3) M) produced a concentration-related relaxation, which was not influenced by treatment with indomethacin, atropine, aminophylline, propranolol, metoprolol, cimetidine, ouabain and methylene blue, and also not by removal of endothelium. Relaxations induced by sophoramine did not differ in strips of proximal and distal coronary arteries. Contractile responses to transmural stimulation in mesenteric arteries and veins were potentiated by treatment with sophoramine (10(-4) M). Treatment with cocaine, indomethacin, propranolol and saralasin did not alter the potentiating effect of sophoramine, whereas yohimbine, an alpha 2 adrenoceptor antagonist, attenuated it. Sophoramine did not significantly affect the contractile response to norepinephrine in mesenteric arteries and veins and the response to phenylephrine and clonidine in mesenteric veins. Sophoramine appears to non-specifically dilate dog arteries and veins and to facilitate the release of transmitter norepinephrine from adrenergic nerves via a mechanism of action on the prejunctional site sensitive to yohimbine.
Asunto(s)
Alcaloides/farmacología , Músculo Liso Vascular/efectos de los fármacos , Vasodilatadores , Fibras Adrenérgicas/efectos de los fármacos , Alcaloides/antagonistas & inhibidores , Animales , Arterias Cerebrales/efectos de los fármacos , Clonidina/farmacología , Vasos Coronarios/efectos de los fármacos , Dinoprost/farmacología , Perros , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Arterias Mesentéricas/efectos de los fármacos , Venas Mesentéricas/efectos de los fármacos , Relajación Muscular/efectos de los fármacos , Músculo Liso Vascular/inervación , Norepinefrina/farmacología , Fenilefrina/farmacología , Yohimbina/farmacologíaRESUMEN
To characterize any digitalis-induced differences in intestinal blood flow autoregulation, we studied the circulatory responses of the rat intestine in control (n = 7) and chronically digitalized (n = 7) animals. Data were generated from denervated isoperfused small intestinal preparations. Arterial pressure, venous pressure, and oxygen consumption were continuously monitored. Determinations of intestinal blood flow allowed calculation of mesenteric vascular resistance and oxygen consumption. Animals underwent stepwise reductions in arterial pressure and acute venous hypertension (10 to 15 mm Hg). There were no differences in baseline hemodynamic or metabolic parameters in control (C) or digitalized (D) animals. Blood flow and oxygen consumption were autoregulated in both C and D rats until perfusion pressure decreased below 50 mm Hg. The response to acute venous hypertension was different. In D rats, venous hypertension resulted in increased vascular resistance (millimeters of mercury per milliliter per minute per 100 gm) [0.89 +/- 0.05 to 0.97 +/- 0.07; p less than 0.05], whereas C rats demonstrated no change [0.92 +/- 0.08 to 0.95 +/- 0.09]. The decrease in oxygen consumption in D rats (-14%) was slightly but significantly greater than that observed in C rats (-9%). Digitalized rats demonstrated a heightened myogenic response to acute venous hypertension with deleterious effects on vascular resistance and oxygen consumption. This reaction was intrinsic to the mesenteric circulation and not mediated by sympathetic nerves or central reflexes. Nonocclusive mesenteric ischemia in digitalized patients may reflect a similar abnormal response to the acute increases in portal pressure accompanying cardiac failure.